Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

4,111 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Sorafenib plus low-dose cisplatin and fluorouracil hepatic arterial infusion chemotherapy versus sorafenib alone in patients with advanced hepatocellular carcinoma (SILIUS): a randomised, open label, phase 3 trial.
Kudo M, Ueshima K, Yokosuka O, Ogasawara S, Obi S, Izumi N, Aikata H, Nagano H, Hatano E, Sasaki Y, Hino K, Kumada T, Yamamoto K, Imai Y, Iwadou S, Ogawa C, Okusaka T, Kanai F, Akazawa K, Yoshimura KI, Johnson P, Arai Y; SILIUS study group. Kudo M, et al. Among authors: arai y. Lancet Gastroenterol Hepatol. 2018 Jun;3(6):424-432. doi: 10.1016/S2468-1253(18)30078-5. Epub 2018 Apr 7. Lancet Gastroenterol Hepatol. 2018. PMID: 29631810 Clinical Trial.
Phase I/II study of hepatic arterial infusion chemotherapy with gemcitabine in patients with unresectable intrahepatic cholangiocarcinoma (JIVROSG-0301).
Inaba Y, Arai Y, Yamaura H, Sato Y, Najima M, Aramaki T, Sone M, Kumada T, Tanigawa N, Anai H, Yoshioka T, Ikeda M; Japan Interventional Radiology in Oncology Study Group (JIVROSG). Inaba Y, et al. Among authors: arai y. Am J Clin Oncol. 2011 Feb;34(1):58-62. doi: 10.1097/COC.0b013e3181d2709a. Am J Clin Oncol. 2011. PMID: 20177362 Clinical Trial.
Transcatheter arterial infusion chemotherapy with a fine-powder formulation of cisplatin for advanced hepatocellular carcinoma refractory to transcatheter arterial chemoembolization.
Iwasa S, Ikeda M, Okusaka T, Ueno H, Morizane C, Nakachi K, Mitsunaga S, Kondo S, Hagihara A, Shimizu S, Satake M, Arai Y. Iwasa S, et al. Among authors: arai y. Jpn J Clin Oncol. 2011 Jun;41(6):770-5. doi: 10.1093/jjco/hyr037. Epub 2011 Apr 1. Jpn J Clin Oncol. 2011. PMID: 21459893
Phase I/II study of radiologic hepatic arterial infusion of fluorouracil plus systemic irinotecan for unresectable hepatic metastases from colorectal cancer: Japan Clinical Oncology Group Trial 0208-DI.
Arai Y, Ohtsu A, Sato Y, Aramaki T, Kato K, Hamada M, Muro K, Yamada Y, Inaba Y, Shimada Y, Boku N, Takeuchi Y, Morita S, Satake M. Arai Y, et al. J Vasc Interv Radiol. 2012 Oct;23(10):1261-7. doi: 10.1016/j.jvir.2012.06.031. Epub 2012 Aug 24. J Vasc Interv Radiol. 2012. PMID: 22922040 Clinical Trial.
Prospective study of transcatheter arterial chemoembolization for unresectable hepatocellular carcinoma: an Asian cooperative study between Japan and Korea.
Ikeda M, Arai Y, Park SJ, Takeuchi Y, Anai H, Kim JK, Inaba Y, Aramaki T, Kwon SH, Yamamoto S, Okusaka T; Japan Interventional Radiology in Oncology Study Group (JIVROSG); Korea Interventional Radiology in Oncology Study Group (KIVROSG). Ikeda M, et al. Among authors: arai y. J Vasc Interv Radiol. 2013 Apr;24(4):490-500. doi: 10.1016/j.jvir.2013.01.003. Epub 2013 Mar 7. J Vasc Interv Radiol. 2013. PMID: 23466316 Clinical Trial.
A randomised phase II study of TSU-68 in patients with hepatocellular carcinoma treated by transarterial chemoembolisation.
Inaba Y, Kanai F, Aramaki T, Yamamoto T, Tanaka T, Yamakado K, Kaneko S, Kudo M, Imanaka K, Kora S, Nishida N, Kawai N, Seki H, Matsui O, Arioka H, Arai Y. Inaba Y, et al. Among authors: arai y. Eur J Cancer. 2013 Sep;49(13):2832-40. doi: 10.1016/j.ejca.2013.05.011. Epub 2013 Jun 10. Eur J Cancer. 2013. PMID: 23764238 Clinical Trial.
4,111 results